• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-375 通过 ASH1 激活,并以谱系依赖的方式抑制肺癌中的 YAP1。

miR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer.

机构信息

Division of Molecular Carcinogenesis, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Japan.

出版信息

Cancer Res. 2011 Oct 1;71(19):6165-73. doi: 10.1158/0008-5472.CAN-11-1020. Epub 2011 Aug 19.

DOI:10.1158/0008-5472.CAN-11-1020
PMID:21856745
Abstract

Lung cancers with neuroendocrine (NE) features are often very aggressive but the underlying molecular mechanisms remain elusive. The transcription factor ASH1/ASCL1 is a master regulator of pulmonary NE cell development that is involved in the pathogenesis of lung cancers with NE features (NE-lung cancers). Here we report the definition of the microRNA miR-375 as a key downstream effector of ASH1 function in NE-lung cancer cells. miR-375 was markedly induced by ASH1 in lung cancer cells where it was sufficient to induce NE differentiation. miR-375 upregulation was a prerequisite for ASH1-mediated induction of NE features. The transcriptional coactivator YAP1 was determined to be a direct target of miR-375. YAP1 showed a negative correlation with miR-375 in a panel of lung cancer cell lines and growth inhibitory activities in NE-lung cancer cells. Our results elucidate an ASH1 effector axis in NE-lung cancers that is functionally pivotal in controlling NE features and the alleviation from YAP1-mediated growth inhibition.

摘要

具有神经内分泌 (NE) 特征的肺癌通常具有很强的侵袭性,但潜在的分子机制仍不清楚。转录因子 ASH1/ASCL1 是肺 NE 细胞发育的主要调节因子,参与具有 NE 特征的肺癌 (NE 肺癌) 的发病机制。在这里,我们报告了 microRNA miR-375 的定义,作为 ASH1 在 NE 肺癌细胞中功能的关键下游效应物。miR-375 在肺癌细胞中被 ASH1 显著诱导,足以诱导 NE 分化。miR-375 的上调是 ASH1 介导的诱导 NE 特征的前提条件。转录共激活因子 YAP1 被确定为 miR-375 的直接靶标。YAP1 在一系列肺癌细胞系中与 miR-375 呈负相关,并在 NE 肺癌细胞中具有生长抑制活性。我们的研究结果阐明了 NE 肺癌中 ASH1 效应轴,该轴在控制 NE 特征和减轻 YAP1 介导的生长抑制方面具有功能重要性。

相似文献

1
miR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer.miR-375 通过 ASH1 激活,并以谱系依赖的方式抑制肺癌中的 YAP1。
Cancer Res. 2011 Oct 1;71(19):6165-73. doi: 10.1158/0008-5472.CAN-11-1020. Epub 2011 Aug 19.
2
A low microRNA-630 expression confers resistance to tyrosine kinase inhibitors in EGFR-mutated lung adenocarcinomas via miR-630/YAP1/ERK feedback loop.低表达 microRNA-630 通过 miR-630/YAP1/ERK 反馈回路赋予 EGFR 突变型肺腺癌对酪氨酸激酶抑制剂的耐药性。
Theranostics. 2018 Feb 2;8(5):1256-1269. doi: 10.7150/thno.22048. eCollection 2018.
3
Roles of achaete-scute homologue 1 in DKK1 and E-cadherin repression and neuroendocrine differentiation in lung cancer.achaete-scute同源物1在肺癌中对DKK1和E-钙黏蛋白的抑制作用及神经内分泌分化中的作用
Cancer Res. 2008 Mar 15;68(6):1647-55. doi: 10.1158/0008-5472.CAN-07-5039.
4
Distinct microRNA Signature and Suppression of ZFP36L1 Define ASCL1-Positive Lung Adenocarcinoma.独特的 microRNA 特征和 ZFP36L1 的抑制定义了 ASCL1 阳性肺腺癌。
Mol Cancer Res. 2024 Jan 2;22(1):29-40. doi: 10.1158/1541-7786.MCR-23-0229.
5
MicroRNA-26a regulates tumorigenic properties of EZH2 in human lung carcinoma cells.微小RNA-26a调节人肺癌细胞中EZH2的致瘤特性。
Cancer Genet. 2012 Mar;205(3):113-23. doi: 10.1016/j.cancergen.2012.01.002.
6
LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.长链非编码 RNA NNT-AS1 通过调控 miR-22-3p/YAP1 轴促进非小细胞肺癌进展。
Thorac Cancer. 2020 Mar;11(3):549-560. doi: 10.1111/1759-7714.13280. Epub 2020 Jan 10.
7
Loss of MiR-424-3p, not miR-424-5p, confers chemoresistance through targeting YAP1 in non-small cell lung cancer.在非小细胞肺癌中,MiR-424-3p而非MiR-424-5p的缺失通过靶向YAP1赋予化疗抗性。
Mol Carcinog. 2017 Mar;56(3):821-832. doi: 10.1002/mc.22536. Epub 2016 Aug 26.
8
ASH1 gene is a specific therapeutic target for lung cancers with neuroendocrine features.ASH1基因是具有神经内分泌特征肺癌的特定治疗靶点。
Cancer Res. 2005 Dec 1;65(23):10680-5. doi: 10.1158/0008-5472.CAN-05-1404.
9
MicroRNA-345 suppresses cell invasion and migration in non-small cell lung cancer by directly targeting YAP1.微小 RNA-345 通过直接靶向 YAP1 抑制非小细胞肺癌细胞的侵袭和迁移。
Eur Rev Med Pharmacol Sci. 2019 Mar;23(6):2436-2443. doi: 10.26355/eurrev_201903_17390.
10
MiR-590-5p, a density-sensitive microRNA, inhibits tumorigenesis by targeting YAP1 in colorectal cancer.MiR-590-5p是一种密度敏感型微小RNA,通过靶向YAP1抑制结直肠癌的肿瘤发生。
Cancer Lett. 2017 Jul 28;399:53-63. doi: 10.1016/j.canlet.2017.04.011. Epub 2017 Apr 19.

引用本文的文献

1
Characteristic miRNA profiles represent clinicopathological diversity of small cell lung cancer.特征性的微小RNA谱代表了小细胞肺癌的临床病理多样性。
J Pathol. 2025 Oct;267(2):168-180. doi: 10.1002/path.6458. Epub 2025 Aug 22.
2
Non-coding RNAs and Hippo signaling in non-small cell lung cancer: emerging roles as biomarkers and therapeutic targets.非编码RNA与非小细胞肺癌中的Hippo信号通路:作为生物标志物和治疗靶点的新作用
Discov Oncol. 2025 Jul 18;16(1):1365. doi: 10.1007/s12672-025-03099-6.
3
Molecular basis and therapeutic implications of binary YAPOn/YAPOff cancer classes.
二元YAP开启/ YAP关闭癌症类别分子基础及治疗意义
Biochem J. 2025 May 28;482(11):741-61. doi: 10.1042/BCJ20253077.
4
Prognostic Significance of , , and in Colon Adenocarcinoma: A Multi-Omics and Single-Cell Approach.,,和在结肠腺癌中的预后意义:一种多组学和单细胞方法
Biomedicines. 2025 Apr 24;13(5):1035. doi: 10.3390/biomedicines13051035.
5
MicroRNAs in lung cancer: their role in tumor progression, biomarkers, diagnostic, prognostic, and therapeutic relevance.肺癌中的微小RNA:它们在肿瘤进展、生物标志物、诊断、预后及治疗相关性中的作用
Discov Oncol. 2025 Mar 11;16(1):293. doi: 10.1007/s12672-025-02054-9.
6
Serum bta-miRNA-375 as a potential biomarker for the early diagnosis of enzootic bovine leukosis.血清 bta-miRNA-375 作为一种潜在的牛白血病地方性流行早期诊断的生物标志物。
PLoS One. 2024 May 9;19(5):e0302868. doi: 10.1371/journal.pone.0302868. eCollection 2024.
7
A plasma miRNA-based classifier for small cell lung cancer diagnosis.一种基于血浆微小RNA的小细胞肺癌诊断分类器。
Front Oncol. 2023 Oct 5;13:1255527. doi: 10.3389/fonc.2023.1255527. eCollection 2023.
8
Unraveling Therapeutic Opportunities and the Diagnostic Potential of microRNAs for Human Lung Cancer.揭示微小RNA在人类肺癌中的治疗机会和诊断潜力
Pharmaceutics. 2023 Jul 31;15(8):2061. doi: 10.3390/pharmaceutics15082061.
9
Extracellular Vesicles Derived circSH3PXD2A Inhibits Chemoresistance of Small Cell Lung Cancer by miR-375-3p/YAP1.细胞外囊泡衍生的 circSH3PXD2A 通过 miR-375-3p/YAP1 抑制小细胞肺癌的化疗耐药性。
Int J Nanomedicine. 2023 Jun 5;18:2989-3006. doi: 10.2147/IJN.S407116. eCollection 2023.
10
PVT1 inhibition stimulates anti-tumor immunity, prevents metastasis, and depletes cancer stem cells in squamous cell carcinoma.PVT1 抑制可刺激抗肿瘤免疫、预防转移并耗竭鳞状细胞癌中的癌症干细胞。
Cell Death Dis. 2023 Mar 9;14(3):187. doi: 10.1038/s41419-023-05710-6.